Save the date for our first Synthetic Biology Industrial Translation Showcase
- Posted on 12 March, 2018
Driving the industrial base of the bioeconomy and advanced manufacturing
In recent years the combined expertise and innovation of UK biologists and engineers has catapulted the UK to the position of being amongst the international leaders in the field of synthetic biology/engineering biology. The opportunity today is to drive growth in the UK bioeconomy, potentially worth trillions of pounds globally, by extending knowledge and understanding of the many industries that can benefit from the field.
This event is set to mark a significant milestone in SynbiCITE’s history. Over the last four years SynbiCITE has played a leading role in successfully putting UK synthetic biology/engineering biology on the agenda for industry, investors and policy makers - as a technology that can make a significant economic impact and a positive difference to the world.
World-leading speakers from industry, academia, investors and government will be participating in the meeting. They will deliver fresh insights on the future of engineering biology, its relevance to the UK economy, and the impact our leading businesses are making on the future of health, agriculture, manufacturing, biofuels, water purification and pharmaceutical & medical technologies.
This is an important event. Some of the most influential thought leaders in the field will converge to address fundamental issues affecting businesses in the field today, as well as strategies for investment and growth. This information exchange is an opportunity not to miss.
This, invitation only, event will take place on Tuesday 5th June 2018, at the Royal Academy of Engineering, London 9am-5pm.
Further information will be made available soon.
Share this article:
People also read
Evonetix collaborates with imec to scale-up chip-based technology production for third generation DNA synthesis platform
CAMBRIDGE, UK, and LEUVEN, Belgium, 13 January 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scala...
Biotech firm MiAlgae secures £1m to turn whisky by-products into pet and fish food
An Edinburgh-based biotech startup which turns whisky distillation by-products into pet and fish food has received investment of £1 million.MiAlgae pr...
Macrophage Pharma Expands Executive Team with Chief Scientific Officer and Chief Technology Officer
Macrophage Pharma Limited ("MPL"), a biotech company focused on the discovery and development of next-generation immunomodulatory small molecules indu...